Karla Santos da Costa Santos da Costa Rosa

Dr. Karla Santos da Costa Santos da Costa Rosa

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

10 July 2021 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
PDF file
EWEMANUELLY WIEGERT
EMANUELLY WIEGERT
KRKarla Santos da Costa Santos da Costa Rosa
Karla Santos da Costa Santos da Costa Rosa
RSRhayara Thacilla Ferreira dos Santos
Rhayara Thacilla Ferreira dos Santos
DSDaiane Almeida dos Santos
Daiane Almeida dos Santos
RFRenata de Freitas
Renata de Freitas
LOLIVIA COSTA DE OLIVEIRA
LIVIA COSTA DE OLIVEIRA

3 December 2020 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Closed access
PDF file
KRKarla Santos da Costa Santos da Costa Rosa
Karla Santos da Costa Santos da Costa Rosa
RCRaphael de Paiva Cypriano
Raphael de Paiva Cypriano
NANathália Masiero Albuquerque
Nathália Masiero Albuquerque
LOLivia Costa de Oliveira
Livia Costa de Oliveira
Background: Prognostic assessment is essential to plan the care of patients with advanced cancer in palliative care. Objective: Thus, this study aims to assess the predictors of death in inpatients with advanced cancer in palliative care. Methods: This is a clinical, observational cohort study with patients aged >20 years, of both genders, evaluated within 48 hours of the first hospitalization. The independent variables were tumor location, nutritional risk [through the Patient-Generated Subjective Global Assessment (PG-SGA) short form], laboratory tests [C-reactive protein and albumin] and Karnofsky Performance Status (KPS). Logistic regression analyses were performed. Results: Eighty-two patients were evaluated, whose mean age was 61.8 (± 13.2) years. Forty-nine (59.8%) patients died during hospitalization, among which the majority had KPS of 30-40% (p-value = 0.043), higher means of the total score of the PG-SGA (p-value = 0.050) and lower serum albumin concentrations (p-value = 0.011). According to the multivariate model, tumor location in the gastrointestinal (GI) tract (OR: 1.73; 95% CI: 1.57-1.94), 30-40% KPS (OR: 1.29; 95% CI: 1.07-1.63) and albumin concentrations <3.5 g/dL (OR: 4.65; 95% CI: 1.22-17.7) were independent factors associated with an increased chance of death from hospitalization. Conclusion: Presenting an advanced tumor with localization in the GI tract, KPS ≤40% and serum albumin concentration <3.5 g/dL at admission were predictors of death in inpatients under palliative care.

18 January 2021 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Open access
PDF file
LOLIVIA COSTA DE OLIVEIRA
LIVIA COSTA DE OLIVEIRA
KRKarla Santos da Costa Santos da Costa Rosa
Karla Santos da Costa Santos da Costa Rosa
ADAna Luísa Durante
Ana Luísa Durante
LRLuciana de Oliveira Ramadas Rodrigues
Luciana de Oliveira Ramadas Rodrigues
DCDaianny Arrais de Oliveira da Cunha
Daianny Arrais de Oliveira da Cunha
SSSimone Garruth dos Santos Machado Sampaio
Simone Garruth dos Santos Machado Sampaio
Background: Advanced cancer patients are part of a group likely to be more susceptible to COVID-19. Aims: To describe the profile of advanced cancer inpatients to an exclusive Palliative Care Unit (PCU) with the diagnosis of COVID-19, and to evaluate the factors associated with death in these cases. Design: Retrospective cohort study with data from advanced cancer inpatients to an exclusive PCU, from March to July 2020, with severe acute respiratory syndrome. Diagnostic of COVID-19 and death were the dependent variables. Logistic regression analyses were performed, with the odds ratio (OR) and 95% confidence interval (CI). Results: One hundred fifty-five patients were selected. The mean age was 60.9 (±13.4) years old and the most prevalent tumor type was breast (30.3%). Eighty-three (53.5%) patients had a diagnostic confirmation of COVID-19. Having diabetes mellitus (OR: 2.2; 95% CI: 1.1-6.6) and having received chemotherapy in less than 30 days before admission (OR: 3.8; 95% CI: 1.2-12.2) were associated factors to diagnosis of COVID-19. Among those infected, 81.9% died and, patients with Karnofsky Performance Status (KPS) < 30% (OR: 14.8; 95% CI 2.7-21.6) and C-reactive protein (CRP) >21.6mg/L (OR: 9.3; 95% CI 1.1-27.8), had a greater chance of achieving this outcome. Conclusion: Advanced cancer patients who underwent chemotherapy in less than 30 days before admission and who had diabetes mellitus were more likely to develop Coronavirus 2019 disease. Among the confirmed cases, those hospitalized with worse KPS and bigger CRP were more likely to die.

7 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Bianca Sakamoto Ribeiro PaivaBianca Sakamoto Ribeiro Paiva
Bianca Sakamoto Ribeiro Paiva
FTFulvio Bergamo Trevizan
Fulvio Bergamo Trevizan
LOLIVIA COSTA DE OLIVEIRA
LIVIA COSTA DE OLIVEIRA
KRKarla Santos da Costa Santos da Costa Rosa
Karla Santos da Costa Santos da Costa Rosa
VBVitória Aparecida Betussi
Vitória Aparecida Betussi
CPCarlos Eduardo Paiva
Carlos Eduardo Paiva
The Go Wish Card Game (GWCG) is emerging as a valuable tool for facilitating end-of-life (EoL) discussions, particularly in oncology care where patients face complex treatment decisions. This review investigates the GWCG’s intended use, its application in oncology settings, and best practices for introducing it to patients. It also addresses the challenges and barriers to its implementation in clinical practice. A search for scientific evidence revealed a significant gap in the literature: while various sources, including qualitative studies and reviews, were reviewed, only a small portion focused on intervention outcomes. This underscores the need for more comprehensive studies to evaluate the GWCG’s effectiveness, especially in EoL care. Despite its potential to foster meaningful conversations and support informed decision-making, successful implementation requires overcoming barriers such as patient resistance and the need for a sensitive, gradual approach to EoL topics. Further research, particularly clinical trials, is essential to confirm its broader applicability and effectiveness.

25 April 2023 in Nutrition
Verified
Journal Article
Closed access
LOLIVIA COSTA DE OLIVEIRA
LIVIA COSTA DE OLIVEIRA
KRKarla Santos da Costa Santos da Costa Rosa
Karla Santos da Costa Santos da Costa Rosa
TGThamiris Gaspar
Thamiris Gaspar
BPBianca Sakamoto Ribeiro Paiva
Bianca Sakamoto Ribeiro Paiva
CPCarlos Eduardo Paiva
Carlos Eduardo Paiva
WPWilza Arantes Ferreira Peres
Wilza Arantes Ferreira Peres